Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

I-Mab Starts US Trial of GM-CSF Immunotherapy for Rheumatoid Arthritis

Xynomic Extends Phase III Abexinostat Trial to China and Europe

CStone Approved to Start China Trial of HDAC6 Inhibitor

CARsgen Approved to Start China Trials of BCMA CAR-T Candidate

CASI Pharma Approved To Start China Trial of Leukemia Treatment

Upcoming event
Shanghai , China
May 8-9, 2019
Take advanage of the early bird discount before March 31, 2019.
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 26-28, 2019